treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..

.

cambridge's bluebird bio licenses delivery tech to novartis, gsk.

subject * .

.

.